Aker BP ASA (AKRBF)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,131	12,340	18,373	19,483	11,633	9,083
Market Cap Growth	-0.33%	-32.84%	-5.70%	67.48%	28.07%	-22.90%
Enterprise Value	20,706	15,386	21,352	22,012	13,942	13,204
Last Close Price	24.15	17.95	25.52	27.19	27.70	20.48
PE Ratio	20.80	6.75	13.76	12.16	14.05	203.14
PS Ratio	1.29	1.00	1.34	1.50	2.04	3.16
PB Ratio	1.28	0.97	1.49	1.57	5.30	4.57
P/FCF Ratio	9.85	7.48	8.22	4.70	4.00	11.76
P/OCF Ratio	2.11	1.92	3.40	3.40	2.72	4.52
EV/Sales Ratio	1.80	1.24	1.56	1.70	2.45	4.60
EV/EBITDA Ratio	2.03	1.40	1.75	1.87	3.08	6.26
EV/EBIT Ratio	2.75	1.82	2.20	2.23	4.30	17.77
EV/FCF Ratio	13.49	9.33	9.55	5.31	4.80	17.09
Debt / Equity Ratio	0.74	0.64	0.53	0.44	1.69	2.11
Debt / EBITDA Ratio	0.84	0.73	0.53	0.46	0.82	1.97
Debt / FCF Ratio	5.67	4.90	2.91	1.31	1.28	5.42
Asset Turnover	0.28	0.31	0.36	0.48	0.39	0.23
Inventory Turnover	2.77	3.43	4.84	5.17	5.84	5.91
Quick Ratio	0.97	1.21	0.83	0.68	1.13	1.02
Current Ratio	1.22	1.37	0.95	0.76	1.20	1.21
Return on Equity (ROE)	5.93%	14.59%	10.78%	21.92%	39.57%	2.05%
Return on Assets (ROA)	11.49%	13.03%	15.82%	22.74%	13.92%	3.77%
Return on Capital (ROIC)	23.52%	26.70%	33.01%	51.96%	33.57%	7.63%
Return on Capital Employed (ROCE)	19.70%	22.50%	28.80%	31.50%	22.80%	6.50%
Earnings Yield	4.81%	14.81%	7.27%	8.23%	7.12%	0.49%
FCF Yield	10.15%	13.36%	12.17%	21.30%	24.97%	8.51%
Dividend Yield	10.21%	13.37%	8.62%	7.36%	4.91%	5.76%
Payout Ratio	213.78%	82.99%	104.09%	62.74%	58.88%	950.46%
Buyback Yield / Dilution	-0.07%	0.01%	-27.08%	-38.13%	0.05%	0.06%
Total Shareholder Return	10.14%	13.39%	-18.46%	-30.77%	4.96%	5.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.